Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
(Q34044910)
scientific article
scientific article
Language:
Current Data About
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
other details
description | scientific article |
External Links
(P356) |
10.1038/LEU.2015.247
|
(P698) |
26369987
|
(P932) |
4746098
|
(P6179) |
1050157516
|